Antisolvent Recrystallization Strategy to Screen Appropriate Carriers to Stabilize Filgotinib Amorphous Solid Dispersions

J Pharm Sci. 2018 Jun;107(6):1624-1632. doi: 10.1016/j.xphs.2018.02.008. Epub 2018 Feb 16.

Abstract

Drugs in amorphous solid dispersions (ASDs) are highly dispersed in hydrophilic polymeric carriers, which also help to restrain recrystallization and stabilize the ASDs. In this study, microscopic observation after antisolvent recrystallization was developed as a rapid screening method to select appropriate polymers for the initial design filgotinib (FTN) ASDs. Using solvent evaporation, FTN ASDs with the polymers were prepared, and accelerated experimentation validated this screening method. Fourier-transform infrared spectroscopy, Raman scattering, and nuclear magnetic resonance revealed hydrogen-bonding formation in the drug-polymer binary system, which was critical for ASDs stabilization. A Flory-Huggins interaction parameter and water sorption isotherms were applied to evaluate the strength of the interaction between FTN and the polymers. The dissolution rate was also significantly improved by ASDs formulation, and the presence of the polymers exerted solubilization effects. These results suggested the efficacy of this screening method as a preliminary tool for polymer selection in ASDs design.

Keywords: amorphous solid dispersions; filgotinib; interaction; polymers; screening method.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Crystallization
  • Drug Carriers / chemistry*
  • Drug Stability
  • Excipients / chemistry*
  • Hypromellose Derivatives / chemistry
  • Janus Kinase 1 / antagonists & inhibitors*
  • Polymers / chemistry*
  • Povidone / chemistry
  • Protein Kinase Inhibitors / administration & dosage
  • Protein Kinase Inhibitors / chemistry*
  • Pyridines / administration & dosage
  • Pyridines / chemistry*
  • Solubility
  • Triazoles / administration & dosage
  • Triazoles / chemistry*

Substances

  • Drug Carriers
  • Excipients
  • GLPG0634
  • Polymers
  • Protein Kinase Inhibitors
  • Pyridines
  • Triazoles
  • Hypromellose Derivatives
  • Janus Kinase 1
  • Povidone